Islet cell therapy - FluidForm Bio
Alternative Names: FRESH 3D bioprinted human islet subcutaneous scaffoldsLatest Information Update: 25 Jul 2025
At a glance
- Originator FluidForm Bio
- Class Cell therapies
- Mechanism of Action Pancreatic beta cell replacements
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Type 1 diabetes mellitus